Vaccination is an effective way to protect against infectious diseases and thus to maintain the health of all population groups. Vaccination gaps can lead to an outbreak of vaccine-preventable diseases. In order to strengthen the vaccination approach, it is particularly important to detect, investigate and transparently communicate real and perceived risks of vaccines in a timely manner. The key to carrying out these measures is receiving the highest possible number of reports of suspected cases of vaccine complications.
In the article "Vaccine Pharmacovigilance Data from 2019 to 2021", the Paul-Ehrlich-Institut provides an overview of the suspected cases of vaccine adverse reactions or vaccine complications reported in this period. Suspected cases were evaluated for all vaccines authorised and marketed in Germany, with the exception of COVID-19 vaccines. Across the board, there were no new risk signals for previously unknown adverse reactions for the vaccines used in Germany on the basis of the suspected cases of adverse reactions or vaccine complications reported to the Paul-Ehrlich-Institut in the years 2019 to 2021.
Updated: 31.03.2023
